Tower Research Capital (TRC)’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $835 | Buy |
|
|||||
|
2024
Q3 | $529 | Sell |
|
|||||
|
2024
Q2 | $14.7K | Buy |
|
|||||
|
2024
Q1 | $508 | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $18K | Sell |
|
|||||
|
2022
Q4 | $43K | Buy |
|
|||||
|
2022
Q3 | $17K | Buy |
|
|||||
|
2022
Q2 | $9K | Sell |
|
|||||
|
2022
Q1 | $39K | Buy |
|
|||||
|
2021
Q4 | $84K | Buy |
|
|||||
|
2021
Q3 | $54K | Sell |
|
|||||
|
2021
Q2 | $136K | Sell |
|
|||||
|
2021
Q1 | $258K | Buy |
|
|||||
|
2020
Q4 | $148K | Sell |
|
|||||
|
2020
Q3 | $181K | Buy |
|
|||||
|
2020
Q2 | $89K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $28K | Buy |
|
|||||
|
2019
Q2 | $3K | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $50K | Buy |
|
|||||
|
2018
Q3 | $12K | Sell |
|
|||||
|
2018
Q2 | $19K | Buy |
|
|||||
|
2018
Q1 | – | Sell |
|
|||||
|
2017
Q4 | $213K | Buy |
|
|||||
|
2017
Q3 | $118K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $1K | Buy |
|
|||||
|
2016
Q4 | $0 | Sell |
|
|||||
|
2016
Q3 | $21K | Buy |
|